Integration sites and genotype distributions of human papillomavirus in cervical intraepithelial neoplasia

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 6, 2013, Pages 3837-3841

  Wang, Li ^a   Dai, Shu Zhen ^a   Chu, Hui Jun ^a   Cui, Hong Fei ^a   Xu, Xiao Yan ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Cervical intraepithelial neoplasia; HPV; HPV genotype; Integration; Preferential sites

Indexed keywords

EID: 84882613242     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.6.3837     Document Type: Article

References (24)

1. Bao YP, Li N, Smith JS, Qiao YL (2008). Human papillomavirus type-distribution in the cervix of Chinese women: a metaanalysis. Int J STD AIDS, 19, 106-11.
2. Bosch FX, Lorincz A, Munoz N, et al (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 55, 244-65..
3. Bosch FX, de Sanjose S (2007). The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers, 23, 213-27.
4. Brown DR, Shew ML, Qadadri B, et al (2005). A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis, 191, 182-92.
5. Clifford GM, Gallus S, Herrero R, et al (2005). Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet, 366, 991-8.
6. Coutlee F, Ratnam S, Ramanakumar AV, et al (2011). Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. J Med Virol, 83, 1034-41.
7. Cricca M, Venturoli S, Leo E, et al (2009). Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions. J Virol Methods, 158, 180-3.
8. Doorbar J (2007). Papillomavirus life cycle organization and biomarker selection. Dis Markers, 23, 297-313.
9. Ho CM, Lee BH, Chang SF, et al (2011). Integration of human papillomavirus correlates with high levels of viral oncogene transcripts in cervical carcinogenesis. Virus Res, 161, 124-30.
10. Li H, Yang Y, Zhang R, et al (2013). Preferential sites for the integration and disruption of human papillomavirus 16 in cervical lesions. J Clin Virol, 56, 342-7.
11. Li J, Zhang D, Zhang Y, et al (2011). Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or high-grade precancerous lesions in Chengdu, western China. Int J Gynaecol Obstet, 112, 131-4.
12. McCredie MR, Sharples KJ, Paul C, et al (2008). Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol, 9, 425-34.
13. Nogara PR, Gimenes F, Consolaro ME (2012). Distribution of HPV genotypes and HPV-16 and HPV-18 E2 gene disruption in South Brazilian women with cervical abnormalities. Int J Gynaecol Obstet, 117, 289-90.
14. Ochi H, Kondo K, Matsumoto K, et al (2008). Neutralizing antibodies against human papillomavirus types 16, 18, 31, 52, and 58 in serum samples from women in Japan with low-grade cervical intraepithelial neoplasia. Clin Vaccine Immunol, 15, 1536-40.
15. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
16. Porras C, Rodriguez AC, Hildesheim A, et al (2009). Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women. Cancer Epidemiol Biomarkers Prev, 18, 863-5.
17. Quek SC, Lim BK, Domingo E, et al (2013). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia. Int J Gynecol Cancer, 23, 148-56.
18. Ramanakumar AV, Goncalves O, Richardson H, et al (2010). Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women. BMC Infect Dis, 10, 326.
19. Schiffman M and Rodriguez AC (2008). Heterogeneity in CIN3 diagnosis. Lancet Oncol, 9, 404-6.
20. Shen Y, Gong JM, Li YQ, et al (2013). Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Henan Province, China. Clin Chim Acta, 415, 297-301.
21. Smith JS, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 121, 621-32.
22. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
23. Wang SS, Hildesheim A (2003). Chapter 5: Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr, 2003, 35-40.
24. Wheeler CM, Hunt WC, Joste NE, et al (2009). Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst, 101, 475-87.